How Deep Tech Brand and Pitch Work Is Scoped

Founders preparing a Series A often ask for a price for a deck, a brand or a website before either side knows what is holding the decision back. A studio can quote a deck quickly. The larger cost sits in the thinking underneath, which covers who the company is for, what it claims and what evidence carries the claim. When that thinking already exists, the work is mostly production. When it is missing, most of the work goes on building it. Sometimes the block sits in the evidence, the economics or the buyer's organisation, and no deck will move it. Scoping has to find out which of these situations the company is in before it names a deliverable.

Scoping starts with what is blocking the decision

The first question in any scope is what the material has to make possible. A raise, a sale or a partnership moves when a specific person takes a specific step. An investor decides whether to enter at this stage. A corporate buyer decides whether to run a paid pilot or reserve future supply. A board decides whether to authorise an expenditure this quarter. Until the decision, its owner and the first commitment being asked for each have a name, any estimate of the work is a guess.

The second question is where the case stops moving. We read the material in the order the decision-maker will meet it and stop at the first unresolved question, unsupported claim or ask they cannot act on. We call that point the First Break. Start With the Decision sets out the method.

What sits behind the First Break sets the scope. Aspyre Foods, which uses duckweed to make proteins for food producers, came to us with a pitch built around one product, casein for cheese, while the company was building a protein platform. Our Aspyre case study records how that shift from product to platform had to be settled before any slide could be designed. The decision about what the company sells came first, and it set what the deck had to carry.

What The Belief Diagnosis is for

When a decision has stalled and the cause is unclear, Brighter Future runs that stage as The Belief Diagnosis. It is a short, bounded piece of work that finds where belief breaks down with investors, buyers or partners and says what needs to change. It names the decision, its owner and the First Break. It then runs six checks before any communications work begins. The checks are Evidence, Economics, Incentives, Authority, Capacity and timing, and Regulation.

The diagnosis decides where any further work sits. That might be a single deck, positioning and messaging, or a full brand with identity and website. It can also find that the next piece of work belongs to the company itself.

Many clients arrive with a clear brief. The company knows what it sells and who decides, and it needs a deck, a website or a positioning job. That work goes straight to scoping, and we answer the questions above in the first conversations.

What the diagnosis can rule out

A studio that sells decks has a reason to find a deck problem. The diagnosis is built to reach a different answer when the case calls for one. The evidence may be too thin for the claim. The economics may not work at the price. The decision may sit with someone the company has not reached. The buyer may be unable to absorb the change this year, or a licence or certification may still stand between the product and the market. In each of those cases better communication describes the constraint more clearly and leaves it in place. Our note on when better communication is the wrong answer works through each one.

When a check fails, Brighter Future will not rebuild the story. The client receives a description of what is missing, in a form somebody can act on. That may be the evidence to generate and the narrower claim that can stand until it exists. It may be the owner the case has to reach, or the date, dependency or threshold the work should resume on.

The diagnosis can also confirm that communication is the constraint. The case may present a number before the comparison that gives it meaning, a mechanism nobody outside the company can restate or an ask the reader cannot act on. Those are problems of order, explanation and structure, and they are the work a studio is for.

How engagements are scoped

Most studios that work with deep tech and climate companies use some mix of three structures.

A fixed diagnosis suits a stalled decision or a problem nobody has yet pinned down. At Brighter Future this is The Belief Diagnosis, and its fee is credited against larger work that follows directly. A clear brief skips this stage and goes straight to a project fee or a retainer.

A project fee covers a defined outcome. Positioning and messaging, an investor deck, an identity or a website each sit here. The scope names the outputs, the rounds of revision and the people involved from the company.

A monthly retainer covers work that keeps moving. A raise running over several months, a launch with many assets or a leadership team that needs support across investor, customer and board meetings all fit this shape. Retainers usually carry a minimum term, because the first month is spent learning the company.

In our experience hourly billing is rare for this kind of work, because the value sits in decisions and decisions do not scale with hours.

Brighter Future agrees scope, outputs and fees for each project before work begins. Our pitch deck design and positioning pages describe what each covers. Choosing a branding studio sets out how we work with founders and where we point them elsewhere.

What moves the scope

Five things drive most of the difference between a small scope and a large one.

The state of the story. A company with a clear position that needs a stronger deck costs less than a company whose investor, customer and website stories describe three different businesses. The first conversations usually show which of the two a company is. When they do not, the diagnosis settles it.

The depth of the science. Technical material takes time to understand well enough to simplify without distortion. A studio that has worked on gas fermentation, environmental DNA sampled from air (eDNA) or forest carbon before will move faster than one meeting the field for the first time. It still has to read the data, speak to the scientists and check each claim.

The number of audiences. A deck for generalist investors is one piece of work. A deck plus a buyer story, a partner story and a website that serves all three is several. DNAir, which collects biological data from air, needed one position that could take industry, public bodies and research partners each to a concrete first use.

Who is in the room. Work that involves the whole leadership team costs more in time and produces more durable decisions. Work that runs through one founder is faster and can be undone later by a co-founder who was not consulted.

What has to be made. Identity systems, websites, video, 3D rendering and launch assets are production. Their cost scales with volume and polish, and it is the easiest part of any quote to compare.

How to compare proposals

Two proposals with the same deliverables can describe very different work. The following questions separate them, and each one can go into the first call with a studio.

Ask how the studio will find out what investors and buyers currently misunderstand. A proposal that starts with design has assumed the answer.

Ask who will do the thinking and who will do the making. In small studios they are often the same people. In larger agencies the strategist may leave after the first workshop.

Ask what happens when the diagnosis finds a problem branding cannot solve, such as missing evidence, weak unit economics or a timing issue. A studio that will say so is protecting your budget.

For a science-led company, ask who will speak with the CSO or head of R&D, how claims are checked before they reach design and how redrawn charts are reviewed against the source data. Ask how the deck will carry into the website, data room and partner material, so the same result is not described three different ways.

Then ask what the studio does when it finds a gap in the evidence. A serious partner names the gap early, separates a missing piece of evidence from a writing problem and helps decide whether the claim should be narrowed, the evidence generated or the slide held back. The deck is stronger when the unresolved part is visible while there is still time to act on it. Our note on what a biotech pitch deck needs covers how those claims are read in technical diligence.

Ask how the work will survive after handover. A deck built from a stable message system can be updated by the team. A deck built as a one-off tends to drift within a quarter.

How to read a deep tech portfolio

A portfolio shows finished surfaces. The useful signal sits underneath them. Look for case studies that name the problem before the design, show what changed in the story and say which audiences the work was built for. A studio that can explain why a company was repositioned has done the thinking. A gallery of logos and slides says little about whether the team understood the science.

Check the range of science too. A studio that has handled fermentation, sensing, carbon and nature finance has learned to ask the questions technical founders expect. Our work sets out the situation, audiences and shift for each project.

Timing against the raise

The most expensive version of this work is the rushed one. Positioning, deck and website built in the three weeks before first meetings leave no room to test the story with friendly investors and change it. In our experience, starting eight to twelve weeks before a round gives time to diagnose, decide, build and rehearse. Starting earlier also lets the website and the deck tell the same story when an investor checks one against the other.

If a raise, a sale or a partnership has stopped moving and the reason is unclear, start with The Belief Diagnosis. It finds where the case stops and decides what work, if any, should follow.

Related reading

• Start With the Decision
• When Better Communication Is the Wrong Answer
• What a Biotech Pitch Deck Needs